AIDS News and Research

RSS

$10.4 million to provide support for HIV/AIDS research in Peru, Thailand, Cambodia and Russia

HHS Secretary Tommy G. Thompson has announced four new grants totaling $10.4 million to provide support for HIV/AIDS research in Peru, Thailand, Cambodia and Russia, four nations that have been hard hit by the AIDS epidemic.

19 Nov 2004

FDA Vioxx fiasco raises questions about AIDS drug approvals for developing world

AIDS Healthcare Foundation (AHF), today noted that the current "FDA fiasco" involving the agency's initial approval and subsequent recall of Merck's troubled arthritis drug, Vioxx, raises serious questions about the FDA's ongoing parallel role in the approval of generic AIDS drugs for widespread use in Africa and the developing world.

19 Nov 2004

Animal research and its benefits to both humans and animals

From preventing polio to finding cures for cancer patients, animal research has saved countless lives.

18 Nov 2004

Biotoxin from puffer fish may provide treatment for opioid withdrawal

On November 10, 2004 investigators involved in a Phase IIa clinical trial of the novel biotoxin Tetrodotoxin (TTX) for the treatment of opioid withdrawal enrolled their first participants.

18 Nov 2004

Generic antipsychotic drugs can protect brain cells from progressive multifocal leukoencephalopathy

Generic antipsychotic drugs can protect brain cells from a virus that causes a fatal nervous system disorder, according to research conducted at Brown University and Case Western Reserve University.

18 Nov 2004

Silicone facial implants provide HAART patients with a healthier appearance

Highly active antiretroviral therapy (HAART) for the treatment of HIV/AIDS is the name given to treatment regimens recommended by leading HIV experts to aggressively suppress viral replication and progress of HIV disease. These treatment regimens have been shown to reduce the amount of virus so that it becomes undetectable in a patient's blood.

16 Nov 2004

Better co-ordination crucial to help reduce maternal and child illness and death

The first of a series of articles looking at public health in complex emergencies (such as famine, population movement arising from civil conflicts and associated health problems) is published in this week’s issue of THE LANCET.

14 Nov 2004

HIV drugs known as protease inhibitors also protect against Malaria

Scientists from The Queensland Institute of Medical Research (QIMR) have found that a group of HIV drugs known as protease inhibitors may also be effective for treating or preventing malaria.

11 Nov 2004

Millions of people threatened by the diabetes time bomb

Millions of lives are threatened by the dual epidemics of diabetes and obesity that are bound to explode in this century, international diabetes and obesity organizations said today in the run up to World Diabetes Day.

11 Nov 2004

Sex genes of infectious fungus closely resemble human Y chromosome

Fungi and animals, including humans, have a lot in common when it comes to the arrangement of genes that determine their sex, according to new work by Howard Hughes Medical Institute geneticists at the Duke University Medical Center.

10 Nov 2004

Testosterone may impede immunity

Decreasing testosterone boosts immunity because testosterone helps control T-lymphocytes, the attack cells of the immune system, according to Mayo Clinic-led research in laboratory animals.

8 Nov 2004

Vaccine contributions to health highlighted at PAHO meeting

Vaccine programs in the Americas have made major contributions to improving health in the Americas and new vaccines could go even further, said Dr. D.A. Henderson, a global expert who chairs a Pan American Health Organization (PAHO) technical group here today.

4 Nov 2004

African American HIV patients treated by white doctors receive life-saving HIV medication later than those who have an African American doctor

"Does Racial Concordance Between HIV-Positive Patients and Their Physicians Affect the Time to Receipt of Protease Inhibitors?" is published in the November issue of the Journal of General Internal Medicine.

4 Nov 2004

Californians say yes on 71

With a clear mandate, the voters of California yesterday overwhelmingly approved Proposition 71, the California Stem Cell Research and Cures Initiative.

4 Nov 2004

Analysis of safety syringe market

One of the biggest challenges facing manufacturers of safety syringes in Europe is the lack of legislation on the use of these products in health care settings.

2 Nov 2004

Cellular enzyme represents a potential new target for developing improved HIV drugs

Scientists have discovered that a cellular enzyme helps ferry HIV genetic instructions out of the cell nucleus where they can then be translated into proteins to begin their most destructive work.

1 Nov 2004

Scientists decode the genome sequence of Cryptosporidium hominis, one of the most common causes of waterborne diseases in humans

A team of scientists at Tufts University School of Veterinary Medicine has helped decode the genome sequence of Cryptosporidium hominis, an insidious parasite identified as one of the most common causes of waterborne diseases in humans and classified by the Centers for Disease Control and Prevention as a potential bioterrorist agent.

29 Oct 2004

AIDS News and Research

$10.4 million to provide support for HIV/AIDS research in Peru, Thailand, Cambodia and Russia

FDA Vioxx fiasco raises questions about AIDS drug approvals for developing world

Animal research and its benefits to both humans and animals

Biotoxin from puffer fish may provide treatment for opioid withdrawal

Generic antipsychotic drugs can protect brain cells from progressive multifocal leukoencephalopathy

Silicone facial implants provide HAART patients with a healthier appearance

Better co-ordination crucial to help reduce maternal and child illness and death

HIV drugs known as protease inhibitors also protect against Malaria

Millions of people threatened by the diabetes time bomb

Sex genes of infectious fungus closely resemble human Y chromosome

Testosterone may impede immunity

Vaccine contributions to health highlighted at PAHO meeting

African American HIV patients treated by white doctors receive life-saving HIV medication later than those who have an African American doctor

Californians say yes on 71

Analysis of safety syringe market

Cellular enzyme represents a potential new target for developing improved HIV drugs

Scientists decode the genome sequence of Cryptosporidium hominis, one of the most common causes of waterborne diseases in humans

Is NICE delivering the goods?

Training of primary care physicians helps increase referrals and cardiac rhythm management device sales

New insights into hormone therapy show when estrogen best aids brain

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News